Teva Canada is recalling some of its Teva-Pregabalin 150 mg capsules after it said routine testing identified possible contamination with the drug sertraline.
Customers with items from affected lots advised to return products to pharmacies
CBC News
·
Listen to this article
Estimated 1 minute
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results.
Teva Canada is recalling some of its Teva-Pregabalin 150 mg capsules after it said routine testing identified possible contamination with the drug sertraline.
The two lots affected by the recall are:
- 100070495
- 100068913
The items were first sold in Canada in September 2025 and have an expiration date of July 31, 2027.
"Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure," according to a recall notice from Health Canada, noting anaphylactic reactions can be fatal.
The agency said anyone with products from the above-mentioned lots should return them to a pharmacy as soon as possible.
Pregabalin is a prescription drug used to treat pain caused by nerve damage. Sertraline is another prescription drug used to relieve symptoms of depression, obsessive-compulsive disorder and panic disorders.
Toronto-based Teva Canada said in its recall notice on Friday that the move is a "precautionary measure."
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.